Foti Caterina, Conserva Anna, Casulli Claudia, Scrimieri Valentina, Pepe Maria Luisa, Quaranta Domenico
Unit of Dermatology, Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Policlinico, Piazza Giulio Cesare, 11, I-70124 Bari, Italy.
Contact Dermatitis. 2007 Jun;56(6):361-2. doi: 10.1111/j.1600-0536.2006.01056.x.
Clostridiopeptidase A, also called collagenase 1, is a proteolytic enzyme capable of digesting collagen. Preparations containing clostridiopeptidase A are used topically for the debridement of dermal ulcers, burns and other necrotic lesions to facilitate the formation of granulation tissue and subsequent epithelization. We observed 4 patients with a periulcerative eczema after repeated applications of Noruxol ointment (Smith & Nephew Ltd, L Hull, UK). Patch testing with Noruxol ointment as is and its excipients (soft paraffin and white petrolatum), as well as scaled dilutions of the main ingredient of this topical preparation, clostridiopeptidase A (Firma, Florence, Italy), showed doubtful reactions to Noruxol ointment in 3 patients and a positive reactions only in 1 patient. All patients showed positive reactions to clostridiopeptidase A 1% in pet. This study shows the sensitizing capacity of clostridiopeptidase A that should be tested in all patients with suspect sensitization to Noruxol ointment.
梭菌肽酶A,也称为胶原酶1,是一种能够消化胶原蛋白的蛋白水解酶。含有梭菌肽酶A的制剂局部用于清创皮肤溃疡、烧伤和其他坏死性病变,以促进肉芽组织的形成和随后的上皮形成。我们观察到4例患者在反复应用诺鲁索软膏(英国赫尔的史密斯&侄子有限公司)后出现溃疡周围湿疹。用诺鲁索软膏原样及其辅料(软石蜡和白凡士林),以及该外用制剂的主要成分梭菌肽酶A(意大利佛罗伦萨的Firma公司)的系列稀释液进行斑贴试验,结果显示3例患者对诺鲁索软膏反应可疑,仅1例患者呈阳性反应。所有患者对1%梭菌肽酶A凡士林制剂均呈阳性反应。本研究表明梭菌肽酶A具有致敏能力,应对所有疑似对诺鲁索软膏过敏的患者进行检测。